Understanding the
Let me start by saying what I am not going to do, and that is to seek to define systems biology! However, it is widely recognized that the chief differences between Systems Biology and traditional molecular biology are (i) the concentration of systems biology (and systems biologists) not on the molecules involved, but on the dynamics of their interactions, and (ii) that systems biology should involve a judicious interplay between modelling, theory, experiment and technology development 1 . As the modelling element is really the key, it is this aspect that I stress here. literature data 7 , and an important feature being the use of principled descriptors for metabolites 5 and their disambiguation 8 from the many synonyms prevailing. A second qualitative stage adds known effectors, while the third and fourth stages add the known kinetic rate equations and the values of their parameters. Armed with such information, preferably encoded properly in a suitable manner, e.g. in the Systems Biology Markup Language (SBML; http://sbml.org/) 9 , it is then possible to provide a stochastic or ordinary differential equation model of the entire metabolic network of interest. Running such a model (using software such as COPASI; www. copasi.org/ 10, 11 ) provides the time evolution of the variables of the system that may be compared with experimental data on the variables. One can then seek to adjust the parameters of the network so that they more nearly reproduce the variables 12 . Methods in which one starts with the variables and seeks to infer the topology and other parameters of the system that generated them are known as inverse methods or system identification methods, and are considerably more demanding computationally (e.g. [13] [14] [15] ). It is also usually the case that such systems are underdetermined, i.e. that many combinations of parameters can give rise to very similar values of the variables. This is in part due to the fact that natural evolution selected for robustness (especially in topology 3 ), which has the advantage (from the experimenter's point of view) that one can then concentrate on those comparatively few (combinations of ) parameters that have the greatest effect 16 .
The purposes and benefits of modelling I have set these out systematically elsewhere 17 , and they include (i) testing whether the model can be made to reflect known experimental facts, (ii)
Although much of what I shall say also applies to signalling pathways, for reasons of focus I shall mainly concentrate on metabolic networks. These also have two especially useful properties over signalling networks, namely that they are subject to specific stoichiometric and thermodynamic constraints that offer considerable advantages in modelling them.
Parameters and variables
It is at once useful to distinguish the parameters and variables of a system (or model thereof ) 2 . The parameters of a dynamical system are those properties of a system that are either inherent to the system of interest or whose values are controlled by an experimenter. In metabolic networks, these include the initial concentrations of enzymes and metabolites, and enzyme kinetic properties such as K m , k cat and K i . The variables, by contrast, are those things that change during the time evolution of the system, typically concentrations of metabolites and metabolic fluxes. It is important to recognize that the parameters control the variables and not vice versa, although it is probably more common to measure the variables than the parameters. Especial virtue attaches to seeking to do both simultaneously (i.e. comparing modelled metabolic networks with their metabolomic properties 3, 4 ).
Metabolic network modelling
It is usual to recognize that the successful modelling of metabolic networks involves a four-stage process 1, 5 . The first two stages are qualitative, with the first involving listing all the reactions that are known to occur in the system or organism of interest; nowadays these reaction lists are mainly derived from genomic annotations 6 , with curation based on three enzymes, as may in fact quite commonly be the case (e.g. 25 ) , in silico analyses allow one to identify them fairly easily (i.e. the computational requirements are very modest, and, because the algorithms can be parallelized efficiently 12 , actually scale close to linearly with the available processors). It is then a simple piece of molecular biology to make the necessary constructs. This fundamental relationship between a small number of important parameters and a very large number of combinations of those parameters means that the modelling strategy is necessarily highly efficient (and really the only sensible way to do industrial biotechnology in the modern era).
Having 20 , it is at least arguable that it is the model itself that represents our knowledge of a biochemical system 21 . Certainly, the recognition that our knowledge is dispersed among multiple databases means that there is advantage to be had in joining them up in a loosely coupled manner 1 , for which we have found the Taverna system (www.taverna.org. uk/) to be of considerable utility 22, 23 . What might we then do with this knowledge
Exploiting our knowledge of biochemical systems properties in biotechnology and medicine
It has long been recognized that the optimization of biotechnological processes needs to be approached rationally 24 (such approaches contrasting with the very sluggish programmes of random mutation and selection that were traditional). The basic issue is that, in part because of the selection by evolution for robustness (something that contrasts with human-made networks such as transport networks, incidentally), it is normally necessary to modify the activities of several different enzymes in order to increase productivity significantly. This involves a purely (and fundamental) combinatorial problem that is much less easily attacked (initially) by experiment than by simulation. This follows because the number of combinations scales exponentially with the number of things one might wish to change, such that choosing combinations of one, two, three or four enzymes from a palette of 1000 involves 1000, 499 500, 1.66×10 8 and 4.14×10 10 possibilities respectively. However, if one does need to change only (say) important aspects, such as iron metabolism 16, 32, 33 , do not depend only on genetically encoded elements, whereas others, such as the transporter molecules important in the cellular uptake of pharmaceutical drugs, remain badly under-recognized [34] [35] [36] [37] . A particular focus for purposes of drug discovery is the recognition that, as with the improvement of biotechnological processes, it is necessary for effective drugs to interact with multiple targets simultaneously 38 (whether with one polypharmacologically active drug 39 or with cocktails 40 ). Abundant evidence suggests that successful drugs have been 'evolutionarily' selected accordingly 32 , whether intentionally or otherwise.
Quo vadis for metabolic systems biology
The problem of biology is (and always has been) the problem of complexity. As we move to ultra-highthroughout measurements of genome sequences and of other '-omes' , personalized medicine will soon be a reality. In agriculture, we can anticipate principled plant and animal breeding, as molecular markers for genotype-phenotype mapping 41 are then available for what amounts to every base. Of the many things one might wish to do with a metabolic network model 4 , visualization remains a key element 42, 43 (e.g. Figure 1 ), as well as the bringing together of our knowledge, for which automated text mining and related methods are going to be de rigueur (e.g. 20, [44] [45] [46] ). We still know much less than we would wish about the interactions between small molecules and proteins 47, 48 , and high-throughput mass spectrometric methods show promise here [49] [50] [51] . Automation is very important 52 . Comparative network analysis, tissuedependent models (see, e.g., http://proteinatlas.org/), comparative metabolomics, genotype-phenotype mapping and inverse problem solving are likely to be among the chief areas of study, all of which contain substantial elements of modelling and computation. It is a truism that 3 months in the laboratory can save one a whole afternoon on the computer. ■ I thank many colleagues for useful discussions. might need improving, the same combinatorial issue pertains for their directed evolution. Thus the number of possible sequences of a protein of 300 amino acids is 20 300 (~10 390 ). The number of sequence variants for m substitutions in a given protein of n amino acids is 19m·n!/[(n−m)!m!]. For a protein of 300 amino acids with changes in just one, two and three amino acids, this is 5700, ~16 million and ~30 billion respectively. However, evolutionary optimization methods 26 can speed up such searches considerably, and I might also point to a recent synthetic biology approach 27 in which we evolved efficient nucleic acid aptamers from a very small number (4×10 4 ) of those (4 30 ≈10 18 ) possible with 30mers. This said, the advance of technology meant that in a related project we could screen all DNA 10mers to understand the nature of the protein sequence-activity landscape 28 . Biomedical applications remain an important focus of systems biology, and one of the goals of metabolic systems biology is the construction of a human metabolic network model 29 , with encouraging progress already reported 30, 31 . Note that some 
